Captor Capital Corp
F:NMVA
EV/OCF
Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.
Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.
Valuation Scenarios
If EV/OCF returns to its 3-Year Average (1.6), the stock would be worth €0.18 (31% downside from current price).
| Scenario | EV/OCF Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 2.4 | €0.26 |
0%
|
| 3-Year Average | 1.6 | €0.18 |
-31%
|
| Industry Average | 10.4 | €1.13 |
+340%
|
| Country Average | 11.9 | €1.3 |
+406%
|
Forward EV/OCF
Today’s price vs future operating cash flow
Peer Comparison
| Market Cap | EV/OCF | P/E | ||||
|---|---|---|---|---|---|---|
| CA |
C
|
Captor Capital Corp
F:NMVA
|
802k EUR | 2.4 | -0 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
924.2B USD | 57.4 | 45.2 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
571.8B USD | 24.6 | 21.6 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
271B CHF | 15.9 | 21 | |
| CH |
|
Novartis AG
SIX:NOVN
|
236.2B CHF | 16.9 | 21.8 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
224.8B GBP | 22.1 | 29.5 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
283.3B USD | 19.4 | 15.7 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 834.6 | -74.6 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 10 | 10.7 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
150.5B USD | 17.3 | 19.8 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
120.4B USD | 10.8 | 17.2 |
Market Distribution
| Min | 0 |
| 30th Percentile | 7.9 |
| Median | 11.9 |
| 70th Percentile | 19.5 |
| Max | 22 577.3 |
Other Multiples
Captor Capital Corp
Glance View
Captor Capital Corp. is an investment company. The company is headquartered in Toronto, Ontario. The company went IPO on 2017-10-30. The firm cultivates, manufactures and distributes medical marijuana-based products to consumers through its brands and dispensary retail stores. The firm provides cannabis products, as well as other cannabis-based goods. The Company’s California joint venture portfolio consists two CHAI Cannabis Co. branded dispensaries, four One Plant branded dispensaries and three additional California cannabis retail licenses for stores under construction. CHAI Santa Cruz is a medical and cannabis dispensary in Santa Cruz County.
